Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myelodysplasia.

R Dansey1

  • 1Karmanos Cancer Institute/Wayne State University, Detroit, MI 48201, USA.

Current Opinion in Oncology
|February 25, 2000
PubMed
Summary

Myelodysplastic syndromes (MDS) are increasing due to aging populations and improved cancer therapies. Research is advancing molecular understanding and treatment options, including transplantation and novel agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Dose Chemotherapy with Bone-Marrow Rescue for Treatment of Relapsed and Refractory Hodgkin's Disease.

Leukemia & lymphoma·2016
Same author

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.

Prostate cancer and prostatic diseases·2012
Same author

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.

Neuropediatrics·2008
Same author

Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.

Neurosurgical focus·2006
Same author

High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.

Journal of clinical microbiology·2005

Area of Science:

  • Hematology
  • Oncology
  • Epidemiology

Background:

  • Myelodysplastic syndromes (MDS) epidemiology is evolving.
  • Increasing disease frequency is linked to aging populations and advanced cancer treatments.
  • Molecular pathogenesis and pathophysiology knowledge are rapidly advancing.

Purpose of the Study:

  • To review current population surveys and case-control studies on MDS epidemiology.
  • To present new information on molecular events in MDS.
  • To discuss evolving treatment strategies for MDS.

Main Methods:

  • Review of recent population surveys and case-control studies.
  • Synthesis of current knowledge on molecular pathogenesis and pathophysiology.
  • Analysis of recent publications on allogeneic transplantation and investigative therapies.

Main Results:

  • MDS incidence is rising, particularly in aging demographics.
  • Significant advancements in understanding MDS molecular mechanisms.
  • Allogeneic transplantation offers curative potential for select MDS patients.
  • Investigative treatments like new chemotherapy, growth factors, and antithymocyte globulin show promise.

Conclusions:

  • MDS epidemiology is changing, with increasing prevalence.
  • Molecular insights are crucial for understanding MDS.
  • Treatment requires individualization, with transplantation as a curative option for some.
  • Novel therapeutic approaches offer hope for improved MDS management.

Related Experiment Videos